1 3583 141 IMPACT OF SHORT- AND LONG-TERM ELECTRICALLY INDUCED MUSCLE EXERCISE ON GENE SIGNALING PATHWAYS, GENE EXPRESSION, AND PGC1A METHYLATION IN MEN WITH SPINAL CORD INJURY. EXERCISE ATTENUATES THE DEVELOPMENT OF CHRONIC NONCOMMUNICABLE DISEASES (NCDS). GENE SIGNALING PATHWAY ANALYSIS OFFERS AN OPPORTUNITY TO DISCOVER IF ELECTRICALLY INDUCED MUSCLE EXERCISE REGULATES KEY PATHWAYS AMONG PEOPLE LIVING WITH SPINAL CORD INJURY (SCI). WE EXAMINED SHORT-TERM AND LONG-TERM DURATIONS OF ELECTRICALLY INDUCED SKELETAL MUSCLE EXERCISE ON COMPLEX GENE SIGNALING PATHWAYS, SPECIFIC GENE REGULATION, AND EPIGENETIC TAGGING OF PGC1A, A MAJOR TRANSCRIPTION FACTOR IN SKELETAL MUSCLE OF MEN WITH SCI. AFTER SHORT- OR LONG-TERM ELECTRICALLY INDUCED EXERCISE TRAINING, PARTICIPANTS UNDERWENT BIOPSIES OF THE TRAINED AND UNTRAINED MUSCLES. RNA WAS HYBRIDIZED TO AN EXON MICROARRAY AND ANALYZED BY A GENE SET ENRICHMENT ANALYSIS. WE DISCOVERED THAT LONG-TERM EXERCISE TRAINING REGULATED THE REACTOME GENE SETS FOR METABOLISM (38 GENE SETS), CELL CYCLE (36 GENE SETS), DISEASE (27 GENE SETS), GENE EXPRESSION AND TRANSCRIPTION (22 GENE SETS), ORGANELLE BIOGENESIS (4 GENE SETS), CELLULAR RESPONSE TO STIMULI (8 GENE SETS), IMMUNE SYSTEM (8 GENE SETS), VESICLE-MEDIATED TRANSPORT (4 GENE SETS), AND TRANSPORT OF SMALL MOLECULES (3 GENE SETS). SPECIFIC GENE EXPRESSION INCLUDED: OXIDATIVE CATABOLISM OF GLUCOSE INCLUDING PDHB (P < 0.001), PDHX (P < 0.001), MPC1 (P < 0.009), AND MPC2 (P < 0.007); OXIDATIVE PHOSPHORYLATION GENES INCLUDING SDHA (P < 0.006), SDHB (P < 0.001), NDUFB1 (P < 0.002), NDUFA2 (P < 0.001); TRANSCRIPTION GENES INCLUDING PGC1ALPHA (P < 0.030) AND PRKAB2 (P < 0.011); HYPERTROPHY GENE MSTN (P < 0.001); AND THE MYOKINE GENERATING FNDC5 GENE (P < 0.008). LONG-TERM ELECTRICALLY INDUCED EXERCISE DEMETHYLATED THE MAJOR TRANSCRIPTION FACTOR PGC1A. TAKEN TOGETHER, THESE FINDINGS SUPPORT THAT LONG-TERM ELECTRICALLY INDUCED MUSCLE ACTIVITY REGULATES KEY PATHWAYS ASSOCIATED WITH MUSCLE HEALTH AND SYSTEMIC METABOLISM. 2020 2 1909 35 ENRICHMENT OF GENOMIC PATHWAYS BASED ON DIFFERENTIAL DNA METHYLATION PROFILES ASSOCIATED WITH CHRONIC MUSCULOSKELETAL PAIN IN OLDER ADULTS: AN EXPLORATORY STUDY. OUR STUDY AIMED TO IDENTIFY DIFFERENTIALLY METHYLATED CPGS/REGIONS AND THEIR ENRICHED GENOMIC PATHWAYS ASSOCIATED WITH UNDERLYING CHRONIC MUSCULOSKELETAL PAIN IN OLDER INDIVIDUALS. WE RECRUITED COGNITIVELY HEALTHY OLDER ADULTS WITH (N = 20) AND WITHOUT (N = 9) SELF-REPORTED MUSCULOSKELETAL PAIN AND COLLECTED DNA FROM PERIPHERAL BLOOD THAT WAS ANALYZED USING METHYLATIONEPIC ARRAYS. WE IDENTIFIED 31,739 HYPERMETHYLATED CPG AND 10,811 HYPOMETHYLATED CPG PROBES (PS 25% OF ENRICHMENT SITES ARE FOUND WITHIN, DOWNSTREAM OR BETWEEN ANNOTATED GENES. LESS THAN 10% OF THESE SITES WERE ALTERED IN MIST1(-/-) ACINI, WITH MOST CHANGES IN H3K4ME3 ENRICHMENT NOT REFLECTING ALTERED GENE EXPRESSION. INGENUITY PATHWAY ANALYSIS OF GENES DIFFERENTIALLY-ENRICHED FOR H3K4ME3 REVEALED AN ASSOCIATION WITH PANCREATITIS AND PANCREATIC DUCTAL ADENOCARCINOMA IN MIST1(-/-) TISSUE. MOST OF THESE GENES WERE NOT DIFFERENTIALLY EXPRESSED BUT SEVERAL WERE READILY INDUCED BY ACUTE EXPERIMENTAL PANCREATITIS, WITH SIGNIFICANTLY INCREASED EXPRESSION IN MIST1(-/-) TISSUE RELATIVE TO WILD TYPE MICE. WE SUGGEST THAT THE CHRONIC CELL STRESS OBSERVED IN THE ABSENCE OF MIST1 RESULTS IN EPIGENETIC REPROGRAMMING OF GENES INVOLVED IN PROMOTING PANCREATITIS TO A POISED STATE, THEREBY INCREASING THE SENSITIVITY TO EVENTS THAT PROMOTE DISEASE. 2014 10 658 25 BLOOD DNA METHYLATION PREDICTS DIABETIC KIDNEY DISEASE PROGRESSION IN HIGH FAT DIET-FED MICE. DIABETIC KIDNEY DISEASE (DKD) PROGRESSES AT DIFFERENT RATES AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2D). EARLY IDENTIFICATION OF PATIENTS WITH A HIGHER RISK OF DKD PROGRESSION IS ESSENTIAL TO IMPROVE PROGNOSIS. EPIGENETIC MODIFICATIONS, PARTICULARLY DNA METHYLATION, HAVE BEEN INDEPENDENTLY IMPLICATED IN T2D AND CHRONIC KIDNEY DISEASE. THE CURRENT STUDY AIMED TO DETERMINE CHANGES IN BLOOD DNA METHYLATION THAT REFLECTS AND PREDICTS DKD PROGRESSION. C57BL/6 MICE WERE FED A HIGH-FAT DIET (HFD) FROM WEANING AND SUBCLASSIFIED INTO TWO GROUPS, HFD-1 AND HFD-2, ACCORDING TO URINARY KIDNEY INJURY MARKER KIM-1/CREATININE RATIOS (LOW VS. HIGH) AND HISTOLOGICAL ABNORMALITIES (MILD-MODERATE VS. ADVANCED). DNA METHYLATION PROFILES WERE DETERMINED BY REDUCED REPRESENTATIVE BISULFIDE SEQUENCING (RRBS). OUR RESULTS CONFIRMED EARLY AND ESTABLISHED DKD AT WEEK 9 AND WEEK 32, RESPECTIVELY. AT WEEK 32, ADVANCED KIDNEY INJURY WAS ASSOCIATED WITH DYSREGULATION OF METHYLATION AND DEMETHYLATION ENZYMES IN THE KIDNEY. BLOOD RRBS REVEALED 579 AND 203 DIFFERENTIALLY METHYLATED SITES (DMS) BETWEEN HFD-1 AND HFD-2 ANIMALS AT WEEK 32 AND WEEK 9, RESPECTIVELY, AMONG WHICH 11 WERE COMMON. THE DMS IN BLOOD AND KIDNEY AT WEEK 32 WERE BOTH RELATED TO ORGAN DEVELOPMENT, NEUROGENESIS, CELL JUNCTION, AND WNT SIGNALLING, WHILE THE DMS IN BLOOD AT WEEK 9 SUGGESTED A SPECIFIC ENRICHMENT OF KIDNEY DEVELOPMENT PROCESSES. IN CONCLUSION, OUR DATA STRONGLY SUPPORT THE IMPLICATION OF EARLY BLOOD DNA METHYLATION MODIFICATIONS AND DKD PROGRESSION IN T2D THAT COULD BE USED TO IMPROVE THE DISEASE'S PROGNOSTICATION. 2022 11 6794 27 [EFFECT OF BENZO(A)PYRENE ON THE EXPRESSION OF AHR-REGULATED MICRORNA IN FEMALE AND MALE RAT LUNGS]. SMOKING IS THE MAIN RISK FACTOR FOR LUNG CANCER, MAINLY DUE TO PRESENCE OF NITROSAMINES AND POLYCYCLIC AROMATIC HYDROCARBONS, INCLUDING BENZO[A]PYRENE (BP) IN TOBACCO SMOKE COMPOSITION. THE GENOTOXIC EFFECT OF BP IS BASED ON THE HIGH DNA-BINDING ABILITY OF ITS METABOLITES, WHILE THE EPIGENETIC EFFECTS ARE MEDIATED BY A CHANGE IN THE EXPRESSION OF CANCER RELATED GENES OR REGULATORY RNAS. IT HAS BEEN SHOWN THAT WOMEN HAVE A HIGHER RISK TO DEVELOP LUNG CANCER UPON SMOKING RATHER THAN MEN. WE HYPOTHESIZED THAT CROSSTALK BETWEEN SIGNALING PATHWAYS ACTIVATED BY BP AND ESTROGENS COULD UNDERLIE THE SEX-DEPENDENT DIFFERENCES IN MIRNAS EXPRESSION. TO TEST THIS HYPOTHESIS, MALE AND FEMALE RATS WERE SUBJECTED TO SHORT-TERM OR LONG-TERM BP EXPOSURE. USING IN SILICO ANALYSIS, MIRNAS CONTAINING THE ER- AND AHR-BINDING SITES IN THE PROMOTERS OF THE GENES (OR HOST GENES) WERE SELECTED. DURING CHRONIC EXPOSURE OF BP THE EXPRESSION OF MIR-22-3P, -29A-3P, -126A-3P, -193B-5P IN THE LUNGS OF MALE RATS WERE SIGNIFICANTLY INCREASED, WHILE THE LEVEL OF MIRNA-483-3P WERE DECREASED. EXPRESSION OF MIRNA-483-3P WAS UP-REGULATED DURING CHRONIC BP EXPOSURE IN THE LUNGS OF FEMALE RATS AND THE LEVELS OF OTHER STUDIED MIRNAS WERE UNCHANGED. IN TURN, CHANGES IN THE EXPRESSION OF MIRNAS WERE FOLLOWED BY CHANGES IN THE EXPRESSION OF THEIR TARGET GENES, INCLUDING PTEN, EMP2, IGF1, ITGA6, SLC34A2, AND THE OBSERVED CHANGES IN FEMALE AND MALE RAT LUNGS WERE VARIED. THUS, OUR RESULTS SUGGEST THAT SEX-DEPENDENT EPIGENETIC EFFECTS OF BP MAY BE BASED ON DIFFERENT EXPRESSION OF AHR- AND ER- REGULATED MIRNAS. 2020 12 1579 36 DNA METHYLATION PROFILE OF LIVER OF MICE CONCEIVED BY IN VITRO FERTILIZATION. OFFSPRING GENERATED BY IN VITRO FERTILIZATION (IVF) ARE BELIEVED TO BE HEALTHY BUT DISPLAY A POSSIBLE PREDISPOSITION TO CHRONIC DISEASES, LIKE HYPERTENSION AND GLUCOSE INTOLERANCE. SINCE EPIGENETIC CHANGES ARE BELIEVED TO UNDERLIE SUCH PHENOTYPE, THIS STUDY AIMED AT DESCRIBING GLOBAL DNA METHYLATION CHANGES IN THE LIVER OF ADULT MICE GENERATED BY NATURAL MATING (FB GROUP) OR BY IVF. EMBRYOS WERE GENERATED BY IVF OR NATURAL MATING. AT 30 WEEKS OF AGE, MICE WERE SACRIFICED. THE LIVER WAS REMOVED, AND GLOBAL DNA METHYLATION WAS ASSESSED USING WHOLE-GENOME BISULFITE SEQUENCING (WGBS). GENOMIC REGIONS FOR ENRICHMENT ANALYSIS TOOL (GREAT) AND G:PROFILERBETA WERE USED TO IDENTIFY DIFFERENTIALLY METHYLATED REGIONS (DMRS) AND FOR FUNCTIONAL ENRICHMENT ANALYSIS. OVERREPRESENTED GENE ONTOLOGY TERMS WERE SUMMARIZED WITH REVIGO, WHILE CANONICAL PATHWAYS (CPS) WERE IDENTIFIED WITH INGENUITY(R) PATHWAY ANALYSIS. OVERALL, 2692 DMRS (4.91%) WERE DIFFERENT BETWEEN THE GROUPS. THE MAJORITY OF DMRS (84.92%) WERE HYPOMETHYLATED IN THE IVF GROUP. SURPRISINGLY, ONLY 0.16% OF CPG ISLANDS WERE DIFFERENTIALLY METHYLATED AND ONLY A FEW DMRS WERE LOCATED ON KNOWN GENE PROMOTERS (N = 283) OR ENHANCERS (N = 190). NOTABLY, THE LONG-INTERSPERSED ELEMENT (LINE), SHORT-INTERSPERSED ELEMENT (SINE), AND LONG TERMINAL REPEAT (LTR1) TRANSPOSABLE ELEMENTS SHOWED REDUCED METHYLATION (P < 0.05) IN IVF LIVERS. CELLULAR METABOLIC PROCESS, HEPATIC FIBROSIS, AND INSULIN RECEPTOR SIGNALING WERE SOME OF THE PRINCIPAL BIOLOGICAL PROCESSES AND CPS MODIFIED BY IVF. IN SUMMARY, IVF MODIFIES THE DNA METHYLATION SIGNATURE IN THE ADULT LIVER, RESULTING IN HYPOMETHYLATION OF GENES INVOLVED IN METABOLISM AND GENE TRANSCRIPTION REGULATION. THESE FINDINGS MAY SHED LIGHT ON THE MECHANISMS UNDERLYING THE DEVELOPMENTAL ORIGIN OF HEALTH AND DISEASE. 2022 13 1965 27 EPIGENETIC ALTERATION OF MITOCHONDRIAL BIOGENESIS REGULATORY GENES IN ARSENIC EXPOSED INDIVIDUALS (WITH AND WITHOUT SKIN LESIONS) AND IN SKIN CANCER TISSUES: A CASE CONTROL STUDY. CHRONIC ARSENIC TOXICITY HAS BECOME A GLOBAL CONCERN DUE TO ITS ADVERSE PATHOPHYSIOLOGICAL OUTCOME AND CARCINOGENIC POTENTIAL. IT IS ALREADY ESTABLISHED THAT ARSENIC INDUCED REACTIVE OXYGEN SPECIES ALTERS MITOCHONDRIAL FUNCTIONALITY. MAJOR REGULATORY GENES FOR MITOCHONDRIAL BIOGENESIS, I.E., PGC1ALPHA, TFAM, NRF1AND NRF2 ARE LOCATED IN THE NUCLEUS. AS A RESULT, MITOCHONDRIA-NUCLEUS CROSSTALK IS CRUCIAL FOR PROPER MITOCHONDRIAL FUNCTION. THIS PREVIOUS HYPOTHESIS LED US TO INVESTIGATEINVOLVEMENT OF EPIGENETIC ALTERATION BEHINDENHANCED MITOCHONDRIAL BIOGENESIS IN CHRONIC ARSENIC EXPOSURE. AN EXTENSIVE CASE-CONTROL STUDY WAS CONDUCTED WITH 390 STUDY PARTICIPANTS (UNEXPOSED, EXPOSED WITHOUT SKIN LESION, EXPOSED WITH SKIN LESION AND EXPOSED SKIN TUMOUR) FROM HIGHLY ARSENIC EXPOSED AREAS OFWEST BENGAL, INDIA. METHYLATION SPECIFIC PCRREVEALED SIGNIFICANT PROMOTER HYPOMETHYLATION OFTWO KEY BIOGENESIS REGULATORY GENES, PGC1ALPHAANDTFAM IN ARSENIC EXPOSED INDIVIDUALS AND ALSO IN SKIN TUMOUR TISSUES. LINEAR REGRESSION ANALYSIS INDICATED SIGNIFICANT NEGATIVE CORRELATION BETWEEN URINARY ARSENIC CONCENTRATION AND PROMOTER METHYLATION STATUS. INCREASED EXPRESSION OF BIOGENESIS REGULATORY GENES WASOBTAINED BY QUANTITATIVE REAL-TIME PCR ANALYSIS. MOREOVER, ALTERED MITOCHONDRIAL FUSION-FISSION REGULATORY GENE EXPRESSION WAS ALSO OBSERVED IN SKIN TUMOUR TISSUES. MIR663, HAVING TUMOUR SUPPRESSOR GENE LIKE FUNCTION WAS KNOWN TO BE EPIGENETICALLY REGULATED THROUGH MITOCHONDRIAL RETROGRADE SIGNAL. PROMOTER HYPERMETHYLATION WITH SIGNIFICANTLY DECREASED EXPRESSION OF MIR663 WAS FOUND IN SKIN CANCER TISSUES COMPARED TO NON-CANCEROUS CONTROL TISSUE. IN CONCLUSION, RESULTS INDICATED CRUCIAL ROLE OF EPIGENETIC ALTERATION IN ARSENIC INDUCED MITOCHONDRIAL BIOGENESIS AND ARSENICAL SKIN CARCINOGENESIS FOR THE FIRST TIME. HOWEVER, FURTHER MECHANISTIC STUDIES ARE NECESSARY FOR DETAILED UNDERSTANDING OF MITOCHONDRIA-NUCLEUS CROSSTALK IN ARSENIC PERTURBATION. 2020 14 4359 27 MIR-422A SUPPRESSES SMAD4 PROTEIN EXPRESSION AND PROMOTES RESISTANCE TO MUSCLE LOSS. BACKGROUND: LOSS OF MUSCLE MASS AND STRENGTH ARE IMPORTANT SEQUELAE OF CHRONIC DISEASE, BUT THE RESPONSE OF INDIVIDUALS IS REMARKABLY VARIABLE, SUGGESTING IMPORTANT GENETIC AND EPIGENETIC MODULATORS OF MUSCLE HOMEOSTASIS. SUCH FACTORS ARE LIKELY TO MODIFY THE ACTIVITY OF PATHWAYS THAT REGULATE WASTING, BUT TO DATE, FEW SUCH FACTORS HAVE BEEN IDENTIFIED. METHODS: THE EFFECT OF MIR-422A ON SMAD4 EXPRESSION AND TRANSFORMING GROWTH FACTOR (TGF)-BETA SIGNALLING WERE DETERMINED BY WESTERN BLOTTING AND LUCIFERASE ASSAY. MIRNA EXPRESSION WAS DETERMINED BY QPCR IN PLASMA AND MUSCLE BIOPSY SAMPLES FROM A CROSS-SECTIONAL STUDY OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND A LONGITUDINAL STUDY OF PATIENTS UNDERGOING AORTIC SURGERY, WHO WERE SUBSEQUENTLY ADMITTED TO THE INTENSIVE CARE UNIT (ICU). RESULTS: MIR-422A WAS IDENTIFIED, BY A SCREEN, AS A MICRORNA THAT WAS PRESENT IN THE PLASMA OF PATIENTS WITH COPD AND NEGATIVELY ASSOCIATED WITH MUSCLE STRENGTH AS WELL AS BEING READILY DETECTABLE IN THE MUSCLE OF PATIENTS. IN VITRO, MIR-422A SUPPRESSED SMAD4 EXPRESSION AND INHIBITED TGF-BETA AND BONE MORPHOGENETIC PROTEIN-DEPENDENT LUCIFERASE ACTIVITY IN MUSCLE CELLS. IN MALE PATIENTS WITH COPD AND THOSE UNDERGOING AORTIC SURGERY AND ON THE ICU, A MODEL OF ICU-ASSOCIATED MUSCLE WEAKNESS, QUADRICEPS EXPRESSION OF MIR-422A WAS POSITIVELY ASSOCIATED WITH MUSCLE STRENGTH (MAXIMAL VOLUNTARY CONTRACTION R = 0.59, P < 0.001 AND R = 0.51, P = 0.004, FOR COPD AND AORTIC SURGERY, RESPECTIVELY). FURTHERMORE, PRE-SURGERY LEVELS OF MIR-422A WERE INVERSELY ASSOCIATED WITH THE AMOUNT OF MUSCLE THAT WOULD BE LOST IN THE FIRST POST-OPERATIVE WEEK (R = -0.57, P < 0.001). CONCLUSIONS: THESE DATA SUGGEST THAT DIFFERENCES IN MIR-422A EXPRESSION CONTRIBUTE TO THE SUSCEPTIBILITY TO MUSCLE WASTING ASSOCIATED WITH CHRONIC AND ACUTE DISEASE AND THAT AT LEAST PART OF THIS ACTIVITY MAY BE MEDIATED BY REDUCED TGF-BETA SIGNALLING IN SKELETAL MUSCLE. 2018 15 2776 32 EXTRAUTERINE GROWTH RESTRICTION ON PULMONARY VASCULAR ENDOTHELIAL DYSFUNCTION IN ADULT MALE RATS: THE ROLE OF EPIGENETIC MECHANISMS. OBJECTIVE: EARLY POSTNATAL LIFE IS CONSIDERED AS A CRITICAL TIME WINDOW FOR THE DETERMINATION OF LONG-TERM METABOLIC STATES AND ORGAN FUNCTIONS. EXTRAUTERINE GROWTH RESTRICTION (EUGR) CAUSES THE DEVELOPMENT OF ADULT-ONSET CHRONIC DISEASES, INCLUDING PULMONARY HYPERTENSION. HOWEVER, THE EFFECTS OF NUTRITIONAL DISADVANTAGES DURING THE EARLY POSTNATAL PERIOD ON PULMONARY VASCULAR CONSEQUENCES IN LATER LIFE ARE NOT FULLY UNDERSTOOD. OUR STUDY WAS DESIGNED TO TEST WHETHER EPIGENETICS DYSREGULATION MEDIATES THE CELLULAR MEMORY OF THIS EARLY POSTNATAL EVENT. METHODS AND RESULTS: TO TEST THIS HYPOTHESIS, WE ISOLATED PULMONARY VASCULAR ENDOTHELIAL CELLS BY MAGNETIC-ACTIVATED CELL SORTING FROM EUGR AND CONTROL RATS. A POSTNATAL INSULT, NUTRITIONAL RESTRICTION-INDUCED EUGR CAUSED DEVELOPMENT OF AN INCREASED PULMONARY ARTERY PRESSURE AT 9 WEEKS OF AGE IN MALE SPRAGUE-DAWLEY RATS. METHYL-DNA IMMUNE PRECIPITATION CHIP, GENOME-SCALE MAPPING STUDIES TO SEARCH FOR DIFFERENTIALLY METHYLATED LOCI BETWEEN CONTROL AND EUGR RATS, REVEALED SIGNIFICANT DIFFERENCE IN CYTOSINE METHYLATION BETWEEN EUGR AND CONTROL RATS. EUGR CHANGES THE CYTOSINE METHYLATION AT APPROXIMATELY 500 LOCI IN MALE RATS AT 9 WEEKS OF AGE, PRECEDING THE DEVELOPMENT OF PULMONARY HYPERTENSION AND THESE REPRESENT THE CANDIDATE LOCI FOR MEDIATING THE PATHOGENESIS OF PULMONARY VASCULAR DISEASE THAT OCCURS LATER IN LIFE. GENE ONTOLOGY ANALYSIS ON DIFFERENTIALLY METHYLATED GENES SHOWED THAT HYPERMETHYLATED GENES IN EUGR ARE VASCULAR DEVELOPMENT-ASSOCIATED GENES AND HYPOMETHYLATED GENES IN EUGR ARE LATE-DIFFERENTIATION-ASSOCIATED AND SIGNAL TRANSDUCTION GENES. WE VALIDATED CANDIDATE DYSREGULATED LOCI WITH THE QUANTITATIVE ASSAYS OF CYTOSINE METHYLATION AND GENE EXPRESSIONS. CONCLUSION: THESE RESULTS DEMONSTRATE THAT EPIGENETICS DYSREGULATION IS A STRONG MECHANISM FOR PROPAGATING THE CELLULAR MEMORY OF EARLY POSTNATAL EVENTS, CAUSING CHANGES IN THE EXPRESSION OF GENES AND LONG-TERM SUSCEPTIBILITY TO PULMONARY HYPERTENSION, AND FURTHER PROVIDING A NEW INSIGHT INTO THE PREVENTION AND TREATMENT OF EUGR-RELATED PULMONARY HYPERTENSION. 2014 16 2653 27 EPIGENOTYPING IN PERIPHERAL BLOOD CELL DNA AND BREAST CANCER RISK: A PROOF OF PRINCIPLE STUDY. BACKGROUND: EPIGENETIC CHANGES ARE EMERGING AS ONE OF THE MOST IMPORTANT EVENTS IN CARCINOGENESIS. TWO ALTERATIONS IN THE PATTERN OF DNA METHYLATION IN BREAST CANCER (BC) HAVE BEEN PREVIOUSLY REPORTED; ACTIVE ESTROGEN RECEPTOR-ALPHA (ER-ALPHA) IS ASSOCIATED WITH DECREASED METHYLATION OF ER-ALPHA TARGET (ERT) GENES, AND POLYCOMB GROUP TARGET (PCGT) GENES ARE MORE LIKELY THAN OTHER GENES TO HAVE PROMOTER DNA HYPERMETHYLATION IN CANCER. HOWEVER, WHETHER DNA METHYLATION IN NORMAL UNRELATED CELLS IS ASSOCIATED WITH BC RISK AND WHETHER THESE IMPRINTS CAN BE RELATED TO FACTORS WHICH CAN BE MODIFIED BY THE ENVIRONMENT, IS UNCLEAR. METHODOLOGY/PRINCIPAL FINDINGS: USING QUANTITATIVE METHYLATION ANALYSIS IN A CASE-CONTROL STUDY (N = 1,083) WE FOUND THAT DNA METHYLATION OF PERIPHERAL BLOOD CELL DNA PROVIDES GOOD PREDICTION OF BC RISK. WE ALSO REPORT THAT INVASIVE DUCTAL AND INVASIVE LOBULAR BC IS CHARACTERIZED BY TWO DIFFERENT SETS OF GENES, THE LATTER PARTICULAR BY GENES INVOLVED IN THE DIFFERENTIATION OF THE MESENCHYME (PITX2, TITF1, GDNF AND MYOD1). FINALLY WE DEMONSTRATE THAT ONLY ERT GENES PREDICT ER POSITIVE BC; LACK OF PERIPHERAL BLOOD CELL DNA METHYLATION OF ZNF217 PREDICTED BC INDEPENDENT OF AGE AND FAMILY HISTORY (ODDS RATIO 1.49; 95% CONFIDENCE INTERVAL 1.12-1.97; P = 0.006) AND WAS ASSOCIATED WITH ER-ALPHA BIOACTIVITY IN THE CORRESPONDING SERUM. CONCLUSION/SIGNIFICANCE: THIS FIRST LARGE-SCALE EPIGENOTYPING STUDY DEMONSTRATES THAT DNA METHYLATION MAY SERVE AS A LINK BETWEEN THE ENVIRONMENT AND THE GENOME. FACTORS THAT CAN BE MODULATED BY THE ENVIRONMENT (LIKE ESTROGENS) LEAVE AN IMPRINT IN THE DNA OF CELLS THAT ARE UNRELATED TO THE TARGET ORGAN AND INDICATE THE PREDISPOSITION TO DEVELOP A CANCER. FURTHER RESEARCH WILL NEED TO DEMONSTRATE WHETHER DNA METHYLATION PROFILES WILL BE ABLE TO SERVE AS A NEW TOOL TO PREDICT THE RISK OF DEVELOPING CHRONIC DISEASES WITH SUFFICIENT ACCURACY TO GUIDE PREVENTIVE MEASURES. 2008 17 3468 31 HYPOXIA-INDUCED DNA HYPERMETHYLATION IN HUMAN PULMONARY FIBROBLASTS IS ASSOCIATED WITH THY-1 PROMOTER METHYLATION AND THE DEVELOPMENT OF A PRO-FIBROTIC PHENOTYPE. BACKGROUND: PULMONARY FIBROSIS IS A DEBILITATING AND LETHAL DISEASE WITH NO EFFECTIVE TREATMENT OPTIONS. UNDERSTANDING THE PATHOLOGICAL PROCESSES AT PLAY WILL DIRECT THE APPLICATION OF NOVEL THERAPEUTIC AVENUES. HYPOXIA HAS BEEN IMPLICATED IN THE PATHOGENESIS OF PULMONARY FIBROSIS YET THE PRECISE MECHANISM BY WHICH IT CONTRIBUTES TO DISEASE PROGRESSION REMAINS TO BE FULLY ELUCIDATED. IT HAS BEEN SHOWN THAT CHRONIC HYPOXIA CAN ALTER DNA METHYLATION PATTERNS IN TUMOUR-DERIVED CELL LINES. THIS EPIGENETIC ALTERATION CAN INDUCE CHANGES IN CELLULAR PHENOTYPE WITH PROMOTER METHYLATION BEING ASSOCIATED WITH GENE SILENCING. OF PARTICULAR RELEVANCE TO IDIOPATHIC PULMONARY FIBROSIS (IPF) IS THE OBSERVATION THAT THY-1 PROMOTER METHYLATION IS ASSOCIATED WITH A MYOFIBROBLAST PHENOTYPE WHERE LOSS OF THY-1 OCCURS ALONGSIDE INCREASED ALPHA SMOOTH MUSCLE ACTIN (ALPHA-SMA) EXPRESSION. THE INITIAL AIM OF THIS STUDY WAS TO DETERMINE WHETHER HYPOXIA REGULATES DNA METHYLATION IN NORMAL HUMAN LUNG FIBROBLASTS (CCD19LU). AS IT HAS BEEN REPORTED THAT HYPOXIA SUPPRESSES THY-1 EXPRESSION DURING LUNG DEVELOPMENT WE ALSO STUDIED THE EFFECT OF HYPOXIA ON THY-1 PROMOTER METHYLATION AND GENE EXPRESSION. METHODS: CCD19LU WERE GROWN FOR UP TO 8 DAYS IN HYPOXIA AND ASSESSED FOR GLOBAL CHANGES IN DNA METHYLATION USING FLOW CYTOMETRY. REAL-TIME PCR WAS USED TO QUANTIFY EXPRESSION OF THY-1, ALPHA-SMA, COLLAGEN I AND III. GENOMIC DNA WAS BISULPHITE TREATED AND METHYLATION SPECIFIC PCR (MSPCR) WAS USED TO EXAMINE THE METHYLATION STATUS OF THE THY-1 PROMOTER. RESULTS: SIGNIFICANT GLOBAL HYPERMETHYLATION WAS DETECTED IN HYPOXIC FIBROBLASTS RELATIVE TO NORMOXIC CONTROLS AND WAS ACCOMPANIED BY INCREASED EXPRESSION OF MYOFIBROBLAST MARKERS. THY-1 MRNA EXPRESSION WAS SUPPRESSED IN HYPOXIC CELLS, WHICH WAS RESTORED WITH THE DEMETHYLATING AGENT 5-AZA-2'-DEOXYCYTIDINE. MSPCR REVEALED THAT THY-1 BECAME METHYLATED FOLLOWING FIBROBLAST EXPOSURE TO 1% O2. CONCLUSION: THESE DATA SUGGEST THAT GLOBAL AND GENE-SPECIFIC CHANGES IN DNA METHYLATION MAY PLAY AN IMPORTANT ROLE IN FIBROBLAST FUNCTION IN HYPOXIA. 2012 18 5269 29 PROMOTER DNA METHYLATION CONTRIBUTES TO HUMAN BETA-DEFENSIN-1 DEFICIENCY IN ATOPIC DERMATITIS. ATOPIC DERMATITIS (AD) IS A CHRONIC INFLAMMATORY SKIN DISEASE CAUSED BY EPIDERMAL BARRIER DYSFUNCTION AND DYSREGULATION OF INNATE AND ADAPTIVE IMMUNITY. EPIGENETIC REGULATION OF HUMAN BETA-DEFENSIN-1 (HBD-1) MIGHT BE ASSOCIATED WITH A VARIETY OF DEFECTS IN THE INNATE IMMUNE SYSTEM DURING AD PATHOGENESIS. WE INVESTIGATED THE POSSIBLE MECHANISM OF DECREASED HBD-1 GENE EXPRESSION IN AD AND DEMONSTRATED THE RESTORATION OF HBD-1 TRANSCRIPTION IN UNDIFFERENTIATED NORMAL HUMAN EPIDERMAL KERATINOCYTE CELLS AFTER TREATMENT WITH A DNA METHYLTRANSFERASE INHIBITOR. WE ALSO CONDUCTED AN IN VITRO METHYLATED REPORTER ASSAY USING A REPORTER CONTAINING 14 CPG SITES. METHYLATION OF THE 14 CPG SITES WITHIN THE HBD-1 5' REGION RESULTED IN AN APPROXIMATELY 86% REDUCTION IN PROMOTER ACTIVITY AND AFFECTED HBD-1 TRANSCRIPTIONAL REGULATION. WE THEN COMPARED METHYLATION FREQUENCIES AT CPG 3 AND CPG 4 BETWEEN NON-LESIONAL AND LESIONAL EPIDERMIS SAMPLES OF PATIENTS WITH SEVERE AD AND BETWEEN THESE PAIRED TISSUES AND HEALTHY CONTROL EPIDERMIS FROM NORMAL VOLUNTEERS WITHOUT AD HISTORY. BISULFITE PYROSEQUENCING DATA SHOWED SIGNIFICANTLY HIGHER METHYLATION FREQUENCIES AT THE CPG 3 AND 4 SITES IN AD LESIONAL SAMPLES THAN IN NON-LESIONAL AD SKIN AND NORMAL SKIN SAMPLES (P < 0.05). THESE RESULTS SUGGEST THAT THE DNA METHYLATION SIGNATURE OF HBD-1 IS A NOVEL DIAGNOSTIC/PROGNOSTIC MARKER AND A PROMISING THERAPEUTIC TARGET FOR THE COMPROMISED STRATUM CORNEUM BARRIER ATTRIBUTED TO HBD-1 DEFICIENCY. 2018 19 217 25 ACUTE EXERCISE INCREASES THE EXPRESSION OF KIR2DS4 BY PROMOTER DEMETHYLATION IN NK CELLS. POSITIVE EFFECTS OF EXERCISE ON CANCER PREVENTION AND PROGRESSION HAVE BEEN PROPOSED TO BE MEDIATED BY STIMULATING NATURAL KILLER (NK) CELLS. BECAUSE NK CELL RECEPTORS ARE REGULATED BY EPIGENETIC MODIFICATIONS, WE INVESTIGATED WHETHER ACUTE AEROBIC EXERCISE AND TRAINING CHANGE PROMOTER DNA METHYLATION AND GENE EXPRESSION OF THE ACTIVATING KIR2DS4 AND THE INHIBITING KIR3DL1 GENE. SIXTEEN HEALTHY WOMEN (50-60 YEARS) PERFORMED A GRADED EXERCISE TEST (GXT) AND WERE RANDOMIZED INTO EITHER A PASSIVE CONTROL GROUP OR AN INTERVENTION GROUP PERFORMING A FOUR-WEEK ENDURANCE EXERCISE INTERVENTION. BLOOD SAMPLES (PRE-, POST-GXT AND POST-TRAINING) WERE USED FOR ISOLATION OF DNA/RNA OF NK CELLS TO ASSESS DNA PROMOTER METHYLATION BY TARGETED DEEP-AMPLICON SEQUENCING AND GENE EXPRESSION BY QRT-PCR. POTENTIAL CHANGES IN NK CELL SUBSETS WERE DETERMINED BY FLOW CYTOMETRY. ACUTE AND CHRONIC EXERCISE DID NOT PROVOKE SIGNIFICANT ALTERATIONS OF NK CELL PROPORTIONS. PROMOTER METHYLATION DECREASED AND GENE EXPRESSION INCREASED FOR KIR2DS4 AFTER ACUTE EXERCISE. A HIGH GENE EXPRESSION CORRELATED WITH A LOW METHYLATION OF CPGS THAT WERE ALTERED BY ACUTE EXERCISE. CHRONIC EXERCISE RESULTED IN A MINOR DECREASE OF DNA METHYLATION AND DID NOT ALTER GENE EXPRESSION. ACUTE EXERCISE PROVOKES EPIGENETIC MODIFICATIONS, AFFECTING THE BALANCE BETWEEN THE ACTIVATING KIR2DS4 AND THE INHIBITING KIR3DL1, WITH POTENTIAL BENEFITS ON NK CELL FUNCTION. 2019 20 3764 31 INTEGRATIVE ANALYSIS OF DNA METHYLATION AND GENE EXPRESSION DATA IDENTIFIES EPAS1 AS A KEY REGULATOR OF COPD. CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IS A COMPLEX DISEASE. GENETIC, EPIGENETIC, AND ENVIRONMENTAL FACTORS ARE KNOWN TO CONTRIBUTE TO COPD RISK AND DISEASE PROGRESSION. THEREFORE WE DEVELOPED A SYSTEMATIC APPROACH TO IDENTIFY KEY REGULATORS OF COPD THAT INTEGRATES GENOME-WIDE DNA METHYLATION, GENE EXPRESSION, AND PHENOTYPE DATA IN LUNG TISSUE FROM COPD AND CONTROL SAMPLES. OUR INTEGRATIVE ANALYSIS IDENTIFIED 126 KEY REGULATORS OF COPD. WE IDENTIFIED EPAS1 AS THE ONLY KEY REGULATOR WHOSE DOWNSTREAM GENES SIGNIFICANTLY OVERLAPPED WITH MULTIPLE GENES SETS ASSOCIATED WITH COPD DISEASE SEVERITY. EPAS1 IS DISTINCT IN COMPARISON WITH OTHER KEY REGULATORS IN TERMS OF METHYLATION PROFILE AND DOWNSTREAM TARGET GENES. GENES PREDICTED TO BE REGULATED BY EPAS1 WERE ENRICHED FOR BIOLOGICAL PROCESSES INCLUDING SIGNALING, CELL COMMUNICATIONS, AND SYSTEM DEVELOPMENT. WE CONFIRMED THAT EPAS1 PROTEIN LEVELS ARE LOWER IN HUMAN COPD LUNG TISSUE COMPARED TO NON-DISEASE CONTROLS AND THAT EPAS1 GENE EXPRESSION IS REDUCED IN MICE CHRONICALLY EXPOSED TO CIGARETTE SMOKE. AS EPAS1 DOWNSTREAM GENES WERE SIGNIFICANTLY ENRICHED FOR HYPOXIA RESPONSIVE GENES IN ENDOTHELIAL CELLS, WE TESTED EPAS1 FUNCTION IN HUMAN ENDOTHELIAL CELLS. EPAS1 KNOCKDOWN BY SIRNA IN ENDOTHELIAL CELLS IMPACTED GENES THAT SIGNIFICANTLY OVERLAPPED WITH EPAS1 DOWNSTREAM GENES IN LUNG TISSUE INCLUDING HYPOXIA RESPONSIVE GENES, AND GENES ASSOCIATED WITH EMPHYSEMA SEVERITY. OUR FIRST INTEGRATIVE ANALYSIS OF GENOME-WIDE DNA METHYLATION AND GENE EXPRESSION PROFILES ILLUSTRATES THAT NOT ONLY DOES DNA METHYLATION PLAY A 'CAUSAL' ROLE IN THE MOLECULAR PATHOPHYSIOLOGY OF COPD, BUT IT CAN BE LEVERAGED TO DIRECTLY IDENTIFY NOVEL KEY MEDIATORS OF THIS PATHOPHYSIOLOGY. 2015